Experimental and Clinical Research Center (ECRC)
As a joint institution of the Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association, the Experimental and Clinical Research Center (ECRC) provides the scientific and technical infrastructure, expertise and resources for translational research, including clinical trials, according to competitive criteria. The ECRC provides access to highly advanced technologies, such as ultra high field magnetic resonance imaging, and has a cleanroom laboratory for the production of immunotherapeutic vaccines and a unique infrastructure for patient-centered research in the form of a clinical pharmacology unit in accordance with the American “clinical research center” model. Studies with outpatients can be carried out in specialized university outpatient clinics. If a clinical trial requires hospitalization of the trial participant for several days, this can be provided in the inpatient hospital sites of the Charité.
The aim is to transform findings from basic research into clinical practice to improve the diagnosis, prevention and treatment of the most prevalent diseases in our society (cardiovascular and metabolic diseases, cancer, neurological disorders). An important aspect of the ECRC strategy is to facilitate extensive collaboration and communication between basic scientists and clinical researchers, thus creating a common platform as the basis for successful cooperation.
Disease genes help early brain development
If the cerebral hemispheres of the forebrain fail to divide properly in an unborn child, this results in holoprosencephaly. An MDC team led by Annette Hammes has discovered candidate genes that can po...more ...
Dr. Michael Frieser is named new Administrative Director of the Berlin Institute of Health at Charité (BIH)
He succeeds Andrea Runow, who has held the post since January 1, 2019, and is now retiring. Dr. Michael Frieser, 55, who currently heads the Administration Division at the Paul-Ehrlich-Institut in Lan...more ...
Johanna Quandt-Professorship for Kathrin de la Rosa
Stiftung Charité Foundation and the Berlin Institute of Health at the Charité are continuing their format for recruiting outstanding female scientists. MDC researcher Kathrin de la Rosa is among the f...more ...
Weiterbildungskurs: Fachkraft für Molekularbiologie (TÜV) vom 8. - 19. November 2021
Das 11-tägige Intensiv-Seminar vermittelt Grundlagenwissen zu den wichtigsten Labormethoden der modernen Molekularbiologie und vermittelt Einblicke in die klinische Forschung. Nutzen Sie auch die Gele...more ...
Good Clinical Practice (GCP)
Good Clinical Practice (GCP) is the ethical and scientific basis for the planning, preparation, conduct and reporting of clinical trials. GCP defines the principles for any clinical trial conducted wi...more ...
Pharmacokinetics - Essentials for Project Managers in Biotech Companies
Basics in understanding pharmacokinetics in clinicial development - for non-physiciansmore ...